LAB TRIACTIV Trademark

Trademark Overview

On Thursday, February 15, 2024, a trademark application was filed for LAB TRIACTIV with the United States Patent and Trademark Office. The USPTO has given the LAB TRIACTIV trademark a serial number of 98406728. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, March 10, 2026. This trademark is owned by Labtician Ophthalmics, Inc.. The LAB TRIACTIV trademark is filed in the Pharmaceutical Products category with the following description:

eye drops; pharmaceutical preparations for the treatment of eye diseases and conditions
lab triactiv

General Information

Serial Number98406728
Word MarkLAB TRIACTIV
Filing DateThursday, February 15, 2024
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, March 10, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 10, 2026

Trademark Statements

NOT AVAILABLE"LAB"
Goods and Serviceseye drops; pharmaceutical preparations for the treatment of eye diseases and conditions

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, February 15, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameLabtician Ophthalmics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressOakville, ON L6H5V5
CA
Party NameLabtician Ophthalmics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressOakville, ON L6H5V5
CA

Trademark Events

Event DateEvent Description
Thursday, February 15, 2024NEW APPLICATION ENTERED
Tuesday, June 18, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, September 7, 2024ASSIGNED TO EXAMINER
Monday, September 9, 2024NON-FINAL ACTION WRITTEN
Monday, September 9, 2024NON-FINAL ACTION E-MAILED
Monday, September 9, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, September 24, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, September 24, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, September 24, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, September 24, 2024SUSPENSION LETTER WRITTEN
Tuesday, September 24, 2024LETTER OF SUSPENSION E-MAILED
Tuesday, September 24, 2024NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, March 25, 2025SUSPENSION INQUIRY WRITTEN
Tuesday, March 25, 2025INQUIRY TO SUSPENSION E-MAILED
Tuesday, March 25, 2025NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Monday, March 31, 2025TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, April 23, 2025ASSIGNED TO LIE
Wednesday, April 23, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 23, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, April 24, 2025SUSPENSION LETTER WRITTEN
Thursday, April 24, 2025LETTER OF SUSPENSION E-MAILED
Thursday, April 24, 2025NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, October 28, 2025SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Friday, January 16, 2026SUSPENSION INQUIRY WRITTEN
Friday, January 16, 2026INQUIRY TO SUSPENSION E-MAILED
Friday, January 16, 2026NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Monday, February 9, 2026TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Monday, February 9, 2026CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, February 9, 2026TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, February 10, 2026APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 4, 2026NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 10, 2026PUBLISHED FOR OPPOSITION
Tuesday, March 10, 2026OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Related Keywords

triactiv diseases conditions treatment preparations pharmaceutical drops